2020年在185个国家的鼻癌发病率和死亡率以及2040年的预计负担:基于人口的全球流行病学分析
Yanting Zhang1, Harriet Rumgay2, Mengmeng Li3,4
1Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
JMIR public health and surveillance
|September 20, 2023
概括
鼻癌 (NPC) 的发病率和死亡率显示全球差异. 这项研究强调了有针对性的控制计划的必要性,特别是在东亚和东南亚,以应对这种头部和部癌症日益增加的负担.
科学领域:
- 流行病学 流行病学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 鼻癌 (NPC) 是头癌中一个重要的全球健康挑战.
- 了解其流行病学分布对于有效的公共卫生战略至关重要.
研究的目的:
- 分析2020年NPC的全球发病率和死亡率.
- 预测到2040年NPC的未来负担.
- 确定有针对性的干预措施的高风险地区和人口.
主要方法:
- 使用了GLOBOCAN 2020的NPC病例和死亡数据.
- 计算的年龄标准化发病率 (ASIR) 和死亡率 (ASMR).
- 2040年就业负担估计的全球人口预测.
主要成果:
- 在2020年,NPC在全球约占133,354例病例和80,008例死亡.
- 东亚,特别是中国,承受了最大的负担.
- 男性的发病率大约是女性的3倍;东南亚和东亚的发病率和死亡率最高.
- 预测显示,到2040年,病例增加34.58%,死亡增加42.29%.
结论:
- 在NPC发病率和死亡率方面,全球仍然存在显著的差异.
- 迫切需要开发和加快NPC控制举措.
- 针对性战略对于东南亚和中国等地区至关重要,以减轻日益增长的NPC负担.
更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
Prevalence and Incidence
621
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
621
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
